Literature DB >> 16299309

Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection.

Paul B Mann1, Daniel Wolfe, Eicke Latz, Douglas Golenbock, Andrew Preston, Eric T Harvill.   

Abstract

Bordetella pertussis, B. parapertussis, and B. bronchiseptica are closely related species associated with respiratory disease in humans and other mammals. While B. bronchiseptica has a wide host range, B. pertussis and B. parapertussis evolved separately from a B. bronchiseptica-like progenitor to naturally infect only humans. Despite very different doubling times in vitro, all three establish similar levels of infection in the mouse lung within 72 h. Recent work has revealed separate roles for Toll-like receptor 4 (TLR4) in immunity to B. pertussis and B. bronchiseptica, while no role for TLR4 during B. parapertussis infection has been described. Here we compared the requirement for TLR4 in innate host defense to these organisms using the same mouse infection model. While B. bronchiseptica causes lethal disease in TLR4-deficient mice, B. pertussis and B. parapertussis do not. Correspondingly, TLR4 is critical in limiting B. bronchiseptica but not B. pertussis or B. parapertussis bacterial numbers during the first 72 h. Interestingly, B. bronchiseptica induces a TLR4-dependent cytokine response that is considerably larger than that induced by B. pertussis or B. parapertussis. Analysis of their endotoxins using RAW cells suggests that B. bronchiseptica lipopolysaccharide (LPS) is 10- and 100-fold more stimulatory than B. pertussis or B. parapertussis LPS, respectively. The difference in LPS stimulus is more pronounced when using HEK293 cells expressing human TLR4. Thus, it appears that in adapting to infect humans, B. pertussis and B. parapertussis independently modified their LPS to reduce TLR4-mediated responses, which may compensate for slower growth rates and facilitate host colonization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299309      PMCID: PMC1307046          DOI: 10.1128/IAI.73.12.8144-8152.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

Review 1.  The Toll receptor family and microbial recognition.

Authors:  R Medzhitov; C Janeway
Journal:  Trends Microbiol       Date:  2000-10       Impact factor: 17.079

Review 2.  Mechanisms of Bordetella pathogenesis.

Authors:  S Mattoo; A K Foreman-Wykert; P A Cotter; J F Miller
Journal:  Front Biosci       Date:  2001-11-01

Review 3.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

4.  Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors.

Authors:  J S Gerber; D M Mosser
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

5.  Human Toll-like receptor 4 recognizes host-specific LPS modifications.

Authors:  Adeline M Hajjar; Robert K Ernst; Jeff H Tsai; Christopher B Wilson; Samuel I Miller
Journal:  Nat Immunol       Date:  2002-03-25       Impact factor: 25.606

6.  Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.

Authors:  E T Harvill; P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.

Authors:  R Medzhitov; P Preston-Hurlburt; C A Janeway
Journal:  Nature       Date:  1997-07-24       Impact factor: 49.962

8.  Structural variability and originality of the Bordetella endotoxins.

Authors:  M Caroff; L Aussel; H Zarrouk; A Martin; J C Richards; H Thérisod; M B Perry; D Karibian
Journal:  J Endotoxin Res       Date:  2001

9.  MHCII, Tlr4 and Nramp1 genes control host pulmonary resistance against the opportunistic bacterium Pasteurella pneumotropica.

Authors:  S K Chapes; D A Mosier; A D Wright; M L Hart
Journal:  J Leukoc Biol       Date:  2001-03       Impact factor: 4.962

10.  Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung.

Authors:  Xiaorong Wang; Christian Moser; Jean-Pierre Louboutin; Elena S Lysenko; Daniel J Weiner; Jeffrey N Weiser; James M Wilson
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

View more
  37 in total

Review 1.  Bordetella pertussis transmission.

Authors:  Elizabeth A Trainor; Tracy L Nicholson; Tod J Merkel
Journal:  Pathog Dis       Date:  2015-09-14       Impact factor: 3.166

2.  Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways.

Authors:  Mingfeng Liu; Constance M John; Gary A Jarvis
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 3.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

4.  Enhancement of Bordetella parapertussis infection by Bordetella pertussis in mixed infection of the respiratory tract.

Authors:  Zoë E V Worthington; Nico Van Rooijen; Nicholas H Carbonetti
Journal:  FEMS Immunol Med Microbiol       Date:  2011-07-29

Review 5.  Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.

Authors:  Nicholas H Carbonetti
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

6.  Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.

Authors:  Gráinne H Long; Alexia T Karanikas; Eric T Harvill; Andrew F Read; Peter J Hudson
Journal:  Proc Biol Sci       Date:  2010-03-03       Impact factor: 5.349

7.  Substitution of the Bordetella pertussis lipid A phosphate groups with glucosamine is required for robust NF-kappaB activation and release of proinflammatory cytokines in cells expressing human but not murine Toll-like receptor 4-MD-2-CD14.

Authors:  Nico Marr; Adeline M Hajjar; Nita R Shah; Alexey Novikov; Cathy S Yam; Martine Caroff; Rachel C Fernandez
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

8.  O antigen protects Bordetella parapertussis from complement.

Authors:  Elizabeth M Goebel; Daniel N Wolfe; Kelly Elder; Scott Stibitz; Eric T Harvill
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

9.  Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.

Authors:  Jeroen Geurtsen; H Alexander Banus; Eric R Gremmer; Henke Ferguson; Liset J J de la Fonteyne-Blankestijn; Jolanda P Vermeulen; Jan A M A Dormans; Jan Tommassen; Peter van der Ley; Frits R Mooi; Rob J Vandebriel
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

10.  Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice.

Authors:  Charlotte Andreasen; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.